043150.KQ
Value Added Technology Co., Ltd.
KOE · Healthcare · Medical - Devices · KR
KRW 18,850.00
+1.78%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 441.0B | 426.4B | 385.2B | 384.9B | 395.1B |
| Cost of Revenue | 212.5B | 218.0B | 181.0B | 179.8B | 197.5B |
| Gross Profit | 228.5B | 208.4B | 204.2B | 205.2B | 197.6B |
| Operating Expenses | |||||
| R&D Expense | 11.9B | 13.7B | 14.2B | 14.3B | 11.2B |
| SG&A Expense | 46.0B | 58.2B | 55.4B | 55.3B | 49.8B |
| General & Admin Expense | 12.8B | 17.2B | 18.4B | 17.2B | 14.5B |
| Selling & Marketing Expense | 33.2B | 41.1B | 37.0B | 38.1B | 35.3B |
| Other Expenses | 114.7B | 81.7B | 80.6B | 71.6B | 57.1B |
| Total Operating Expenses | 168.3B | 153.6B | 150.2B | 141.1B | 118.1B |
| Cost and Expenses | 380.9B | 371.6B | 331.2B | 321.0B | 315.6B |
| Operating Income (EBIT) | 60.2B | 54.8B | 54.0B | 64.0B | 79.4B |
| Non-Operating | |||||
| Interest Income | 5.3B | 4.8B | 4.6B | 4.1B | 2.6B |
| Interest Expense | 2.5B | 2.6B | 2.2B | 2.5B | 1.6B |
| Net Interest Income | 2.8B | 2.3B | 2.3B | 1.6B | 1.1B |
| Other Non-Op Income/Expense | 15.7B | 392.1M | 18.3B | 2.7B | 18.1B |
| Non-Operating Income (excl Interest) | (4.0B) | — | (20.6B) | (5.2B) | (4.7B) |
| EBT (Pre-Tax Income) | 75.8B | 55.2B | 72.3B | 66.7B | 97.6B |
| Income Tax Expense | 19.4B | 16.1B | 17.0B | 13.8B | 18.9B |
| Bottom Line | |||||
| Net Income | 57.4B | 40.1B | 55.1B | 51.7B | 76.9B |
| Earnings from Cont. Ops | 56.5B | 39.1B | 55.3B | 53.0B | 78.6B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 57.4B | 40.1B | 55.1B | 51.7B | 76.9B |
| Per Share | |||||
| Basic EPS | ₩3,863 | ₩2,701 | ₩3,712 | ₩3,483 | ₩5,176 |
| Diluted EPS | ₩3,863 | ₩2,701 | ₩3,712 | ₩3,483 | ₩5,176 |
| Revenue Per Share | ₩29,985 | ₩29,461 | ₩25,932 | ₩25,915 | ₩26,596 |
| Shares | |||||
| Basic Shares Outstanding | 14.7M | 14.5M | 14.9M | 14.9M | 14.9M |
| Diluted Shares Outstanding | 14.7M | 14.5M | 14.9M | 14.9M | 14.9M |
| Profitability Metrics | |||||
| EBITDA | 83.6B | 71.6B | 83.0B | 83.9B | 95.7B |
| D&A | 17.1B | 16.9B | 15.1B | 14.6B | 11.6B |
| EBIT | 66.4B | 54.8B | 67.9B | 69.3B | 84.2B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026